DiaSorin Statistics
Total Valuation
DiaSorin has a market cap or net worth of 6.03 billion. The enterprise value is 6.75 billion.
| Market Cap | 6.03B |
| Enterprise Value | 6.75B |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 21.69M |
Valuation Ratios
The trailing PE ratio is 30.98.
| PE Ratio | 30.98 |
| Forward PE | n/a |
| PS Ratio | 4.92 |
| PB Ratio | 3.24 |
| P/TBV Ratio | 28.95 |
| P/FCF Ratio | 19.00 |
| P/OCF Ratio | 16.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.78, with an EV/FCF ratio of 21.27.
| EV / Earnings | 34.68 |
| EV / Sales | 5.01 |
| EV / EBITDA | 15.78 |
| EV / EBIT | 22.27 |
| EV / FCF | 21.27 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.56.
| Current Ratio | 3.51 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | 2.69 |
| Debt / FCF | 3.31 |
| Interest Coverage | 10.11 |
Financial Efficiency
Return on equity (ROE) is 11.21% and return on invested capital (ROIC) is 6.01%.
| Return on Equity (ROE) | 11.21% |
| Return on Assets (ROA) | 5.12% |
| Return on Invested Capital (ROIC) | 6.01% |
| Return on Capital Employed (ROCE) | 8.80% |
| Revenue Per Employee | 374,284 |
| Profits Per Employee | 59,392 |
| Employee Count | 3,308 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.25% in the last 52 weeks. The beta is 0.40, so DiaSorin's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +23.25% |
| 50-Day Moving Average | 107.39 |
| 200-Day Moving Average | 103.88 |
| Relative Strength Index (RSI) | 52.05 |
| Average Volume (20 Days) | 0 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DiaSorin had revenue of 1.23 billion and earned 194.75 million in profits. Earnings per share was 3.49.
| Revenue | 1.23B |
| Gross Profit | 809.83M |
| Operating Income | 276.14M |
| Pretax Income | 251.01M |
| Net Income | 194.75M |
| EBITDA | 377.85M |
| EBIT | 276.14M |
| Earnings Per Share (EPS) | 3.49 |
Balance Sheet
The company has 392.30 million in cash and 1.05 billion in debt, giving a net cash position of -658.08 million.
| Cash & Cash Equivalents | 392.30M |
| Total Debt | 1.05B |
| Net Cash | -658.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.86B |
| Book Value Per Share | 34.60 |
| Working Capital | 716.31M |
Cash Flow
In the last 12 months, operating cash flow was 371.45 million and capital expenditures -53.96 million, giving a free cash flow of 317.48 million.
| Operating Cash Flow | 371.45M |
| Capital Expenditures | -53.96M |
| Free Cash Flow | 317.48M |
| FCF Per Share | n/a |
Margins
Gross margin is 65.99%, with operating and profit margins of 22.50% and 15.87%.
| Gross Margin | 65.99% |
| Operating Margin | 22.50% |
| Pretax Margin | 20.45% |
| Profit Margin | 15.87% |
| EBITDA Margin | 30.79% |
| EBIT Margin | 22.50% |
| FCF Margin | 25.87% |
Dividends & Yields
DiaSorin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 32.58% |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | 3.23% |
| FCF Yield | 5.26% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DiaSorin has an Altman Z-Score of 3.73.
| Altman Z-Score | 3.73 |
| Piotroski F-Score | n/a |